← FDA Drug Approvals (Drugs@FDA)

BREXPIPRAZOLE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AJANTA PHARMA LTD · Approved 2023-02-03

Drug application

FDA Application #

ANDA213718

Application type

Abbreviated New Drug Application (Generic)

Brand name

BREXPIPRAZOLE

Generic name

BREXPIPRAZOLE

Active ingredients

BREXPIPRAZOLE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

AJANTA PHARMA LTD

Manufacturer

Ajanta Pharma USA Inc.

First approval

2023-02-03

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown